The present application relates to the technical field of
traditional Chinese medicine, and particularly relates to a
traditional Chinese medicine composition for treating chronic obstructive
pulmonary disease and application thereof, and an
active ingredient of the
traditional Chinese medicine composition is prepared from the following raw materials by weight: 10-30 parts of fried
astragalus, 2-10 parts of
ginseng, 5-15 parts of atractylodes, 5-15 parts of radix morindae
officinalis, 1-8 parts of leech, 2-10 parts of
fructus aurantii immaturus, and 10-30 parts of mulberry root-
bark. Based on the theory of Zongyuan and long-term clinical practice, the present application first proposes that the core
pathogenesis of chronic obstructive
pulmonary disease is "Zongyuan deficiency", and the traditional Chinese
medicine composition formula is synthesized by taking fried
astragalus and
ginseng as monarch drugs, atractylodes and radix morindae
officinalis as ministerial drugs, and leech,
fructus aurantii immaturus and mulberry root-
bark as auxiliary drugs. The
combined use of the drugs has the effects of tonifying Zongyuan, promoting
blood circulation to resolve
phlegm, relieving cough and
asthma. Clinical application shows that the traditional Chinese
medicine composition provided by the present application can effectively improve the clinical symptoms such as cough,
sputum and
asthma of patients with chronic obstructive
pulmonary disease, reduce
airway mucus hypersecretion, improve exercise tolerance, and possibly reduce acute
exacerbation, so as to slow down the development process of chronic obstructive pulmonary
disease.